|
|
||||||||
q and PLC-
protein
abundance in cardiac hypertrophy and failure
Department of Medicine, Case Western Reserve University, University Hospital of Cleveland, Cleveland, Ohio 44106-5029
Activation of
protein kinase C (PKC) has been implicated as playing a key role in the
pathogenesis of cardiac hypertrophy. This study investigates the
response of several signal transduction proteins responsible for PKC
activation during the transition from compensated pressure-overload
hypertrophy (POH) to congestive heart failure (CHF). Pressure overload
was produced on male, adult, Hartley strain guinea pigs using a
ligature around the descending thoracic aorta. Sham-operated controls,
POH, and CHF groups were identified based on left ventricular
hypertrophy, pulmonary congestion, and isolated heart Langendorff
mechanics. Quantitative immunoblotting revealed phospholipase C
(PLC)-
I and G
q were
unchanged during POH and CHF, as were RGS2, RGS3, and RGS4 (regulators
of G protein signaling, which are activators of intrinsic GTPase
activity). Translocation of PKC-
, -
, and -
from cytosolic to
membranous fractions were significantly increased during POH and CHF.
Cytosolic PKC activity was also elevated during POH. We conclude that
differential PKC activation may be mediated by increases in
G
q and PLC-
I activity rather
than upregulation of expression.
heart failure; G proteins; protein kinase C; regulators of G protein signaling
This article has been cited by other articles:
![]() |
Z.-F. Lai, Y.-Z. Chen, L.-P. Feng, X.-M. Meng, J.-F. Ding, L.-Y. Wang, J. Ye, P. Li, X.-S. Cheng, Y. Kitamoto, et al. Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H708 - H716. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Niizeki, Y. Takeishi, T. Kitahara, T. Arimoto, M. Ishino, O. Bilim, S. Suzuki, T. Sasaki, O. Nakajima, R. A. Walsh, et al. Diacylglycerol kinase-{varepsilon} restores cardiac dysfunction under chronic pressure overload: a new specific regulator of G{alpha}q signaling cascade Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H245 - H255. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kong, M. Andrassy, J. S. Chang, C. Huang, T. Asai, M. J. Szabolcs, S. Homma, R. Liu, Y. S. Zou, M. Leitges, et al. PKC{beta} modulates ischemia-reperfusion injury in the heart Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1862 - H1870. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Roman, P. H. Goldspink, E. Spaite, D. Urboniene, R. McKinney, D. L. Geenen, R. J. Solaro, and P. M. Buttrick Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2089 - H2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jalili, J. Manning, and S. Kim Increased Translocation of Cardiac Protein Kinase C {beta}2 Accompanies Mild Cardiac Hypertrophy in Rats Fed Saturated Fat J. Nutr., February 1, 2003; 133(2): 358 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kerkela, M. Ilves, S. Pikkarainen, H. Tokola, J. Ronkainen, O. Vuolteenaho, J. Leppaluoto, and H. Ruskoaho Identification of PKCalpha Isoform-Specific Effects in Cardiac Myocytes Using Antisense Phosphorothioate Oligonucleotides Mol. Pharmacol., December 1, 2002; 62(6): 1482 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. G. Pyle, M. P. Sumandea, R. J. Solaro, and P. P. De Tombe Troponin I serines 43/45 and regulation of cardiac myofilament function Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1215 - H1224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Braz, O. F. Bueno, L. J. De Windt, and J. D. Molkentin PKC{alpha} regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2) J. Cell Biol., March 4, 2002; (2002) 200108062. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pass, J. Gao, W. K. Jones, W. B. Wead, X. Wu, J. Zhang, C. P. Baines, R. Bolli, Y.-T. Zheng, I. G. Joshua, et al. Enhanced PKCbeta II translocation and PKCbeta II-RACK1 interactions in PKCepsilon -induced heart failure: a role for RACK1 Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2500 - H2510. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Roman, D. L. Geenen, M. Leitges, and P. M. Buttrick PKC-{beta} is not necessary for cardiac hypertrophy Am J Physiol Heart Circ Physiol, May 1, 2001; 280(5): H2264 - H2270. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, H. Hahn, G. Wu, C.-H. Chen, T. Liron, D. Schechtman, G. Cavallaro, L. Banci, Y. Guo, R. Bolli, et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and varepsilon PKC PNAS, September 25, 2001; 98(20): 11114 - 11119. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Braz, O. F. Bueno, L. J. De Windt, and J. D. Molkentin PKC{alpha} regulates the hypertrophic growth of cardiomyocytes through extracellular signal-regulated kinase1/2 (ERK1/2) J. Cell Biol., March 4, 2002; 156(5): 905 - 919. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |